Login

Realm Therapeutics plc - Equity Development Investor Forum - Alex Martin, CEO, Realm Therapeutics 00:00:00

Share On Facebook Share On Twitter

Realm Therapeutics plc - Equity Development Investor Forum

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
V.P. of Colt CZ Group's Commercial Business Paul Spitale discusses new Colt weapons and the company's merger with CZ. | Jan Drahota, CEO, Colt CZ Group SECZG:PRA
00:10:00
Future-Proofing Tomorrow: WSP’s 2019-2021 Global Strategic Vision | Leadership for Resilient Cities and Sustainable Communities
00:10:00
Care Pay: Revolutionizing Healthcare Costs with Transparent Pricing
00:10:00
Global Nickel Market: Challenges and Opportunities
00:00:00
Tal Yalon, M.D., Mayo Clinic
00:10:00
AXA CEO Thomas Buberl Discusses Emerging Virus Threats and Insurance Industry Impacts
00:10:00
Bond Market Turmoil: Understanding the Recent Challenges and Future Strategies | Sébastien Page, CIO , T. Rowe Price.
00:10:00
To be a preeminent global investment manager by delivering superior risk-adjusted returns over the long term|Ryan Tolkin,Chief Executive Officer,Schonfeld Strategic Advisors
00:10:00
The Indoctrination of the American Mind: Critical Race Theory and Education|Eric Kaufmann,Professor,University of Buckingham
00:10:00
Exploring Private Equity Insights with Ian Snow, CEO of Snow Phipps Group
00:10:00
Ed Richardson, Chairman, President, and CEO of Richardson Electronics, Ltd. (NASDAQ: RELL), discusses the company's developments via Zoom.
00:10:00
Interview Transcript with the CEO of Biosynth

© 2017 - Neuhu+